TABLE 3

NOPR Working Group's Priority Areas for Early Evaluation

Priority and relative frequencyDiagnosisStagingRestaging and suspected recurrenceTherapeutic monitoring
1Pancreatic cancerPancreatic cancerOvarian cancerLymphoma
2Cancer of unknown primary siteSmall cell lung cancerBrain tumorsNon–small cell lung cancer
3Ovarian cancerCervical cancerMetastatic colorectal cancer
4Multiple myelomaMultiple myelomaHead and neck cancer
5Esophageal cancer